Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing Pathway
Lauren Shih, Perrin Romine, Mara Roth, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2023
Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy
Charles B Simone, Artur A Serebrenik, Elizabeth M Gore, et al.
JTO Clinical and Research Reports
|
November 18, 2024
High-Grade Pneumonitis Events in Patients With Unresectable, Locally Advanced NSCLC Treated With Definitive Chemoradiation Followed by Adjuvant Durvalumab
Ciani Ellison, Michael Martens, Juliana Alvarez Argote, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 24, 2018
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC
Jessica J Lin, Viola W Zhu, Adam J Schoenfeld, et al.
The Oncologist
|
June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing Pathway
Lauren Shih, Perrin Romine, Mara Roth, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2023
Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy
Charles B Simone, Artur A Serebrenik, Elizabeth M Gore, et al.
JTO Clinical and Research Reports
|
November 18, 2024
High-Grade Pneumonitis Events in Patients With Unresectable, Locally Advanced NSCLC Treated With Definitive Chemoradiation Followed by Adjuvant Durvalumab
Ciani Ellison, Michael Martens, Juliana Alvarez Argote, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 24, 2018
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC
Jessica J Lin, Viola W Zhu, Adam J Schoenfeld, et al.
The Oncologist
|
June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
Page
of 2